Objective: Evaluation the effect of daily intake calcium on serum B12 levels in people with type II diabetes mellitus who are used metformin
Study design: Random (block randomization size of 4, 8, 10), one blind side, control with placebo, single central
Experimental population: All people with type II diabetes mellitus who are used metformin referred to the endocrinology clinic of Shahid Beheshti Hospital of Qom
Inclusion criteria: people with type II diabetes mellitus are treated to metformin in aged 30 to 60 years; People with type II diabetes mellitus are treated to metformin for the last 2 years; diabetics are treated with 1 to 2 gram metformin.
Exclusion criteria: Current intake of calcium or B12 vitamin supplements; people with malabsorption, renal failure, kidney stone, liver disease, lung disease, anemia, gastrointestinal surgery, cancer, antibiotic use in the last two weeks; people with B12 vitamin deficiency
Sample size, intervention, intervention time and outcome of the study: sample size of this study is 60 persons will be divided into two groups (Intervention and Control groups).
Intervention group: To each patients are given metformin with 200 pcs of calcium carbonate tablet (daily 1 gram). The serum B12 level and neuropathy will be measured after 3 months of calcium uptake.
Control group: To each patients are given metformin with 200 pcs of placebo tablet.
Patients will be monitored that how to use of tablets for monthly by telephone. Medicine or placebo prescribing will be perform by project secretary with encoding in a particular office without the knowledge of participants.